Heritability in frontotemporal dementia: more missing pieces?

Journal of Neurology

Volumn 261, Issue 11, 2014, Pages 2170-2177

  Po, Kieren ^a,b   Leslie, Felicity V C ^c   Gracia, Natalie ^c   Bartley, Lauren ^c   Kwok, John B J ^a,c,d   Halliday, Glenda M ^a,c,d   Hodges, John R ^a,c,d   Burrell, James R ^a,c,d  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alzheimer's disease; C9ORF72 repeat expansion; Frontotemporal dementia; Genetics; Modified Goldman score; Progranulin; Tau

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; SCREENING TEST; GENETIC SCREENING; GENETICS; MIDDLE AGED; PROCEDURES;

AGED; ALZHEIMER DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED;

EID: 84920991937     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7474-9     Document Type: Article

References (37)

1. Gandhi S, Wood NW (2010) Genome-wide association studies: the key to unlocking neurodegeneration? Nat Neurosci 13:789–794. doi:10.1038/nn.2584
2. Ramanan VK, Saykin AJ (2013) Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am J Neurodegener Dis 2:145–175
3. Swerdlow RH, Corder EH (2012) For Alzheimer disease GWAS, pulling needles from the haystack is just the first step. Neurology 79:204–205. doi:10.1212/WNL.0b013e318260581d
4. Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615–1621
5. Goldman JS, Farmer JM, Wood EM et al (2005) Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65:1817–1819
6. Rosso SM, Kaat LD, Baks T et al (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126:2016–2022. doi:10.1093/brain/awg204
7. Rohrer JD, Guerreiro R, Vandrovcova J et al (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73:1451–1456. doi:10.1212/WNL.0b013e3181bf997a
8. Le Ber I, Guedj E, Gabelle A et al (2006) Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 129:3051–3065
9. Mackenzie IRA, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127:347–357. doi:10.1007/s00401-013-1232-4
10. Sieben A, Van Langenhove T, Engelborghs S et al (2012) The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 124:353–372. doi:10.1007/s00401-012-1029-x
11. DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256. doi:10.1016/j.neuron.2011.09.011
12. Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268. doi:10.1016/j.neuron.2011.09.010
13. Smits LL, Pijnenburg YAL, Koedam ELGE et al (2012) Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30:101–108. doi:10.3233/JAD-2012-111934
14. Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456–2477. doi:10.1093/brain/awr179
15. Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014
16. Strong MJ, Grace GM, Freedman M et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:131–146
17. McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939
18. Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatr 83:405–410. doi:10.1136/jnnp-2011-300875
19. Burrell JR, Hornberger M, Villemagne VL et al (2013) Clinical profile of PiB-positive corticobasal syndrome. PLoS One 8:e61025. doi:10.1371/journal.pone.0061025
20. Dobson-Stone C, Hallupp M, Bartley L et al (2012) C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79:995–1001. doi:10.1212/WNL.0b013e3182684634
21. Devenney E, Hornberger M, Irish M et al (2014) Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol 71:331–339. doi:10.1001/jamaneurol.2013.6002
22. Mahoney CJ, Beck J, Rohrer JD et al (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135:736–750. doi:10.1093/brain/awr361
23. Wood EM, Falcone D, Suh E et al (2013) Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol 70:1411–1417. doi:10.1001/jamaneurol.2013.3956
24. Rubino E, Rainero I, Chiò A et al (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79:1556–1562. doi:10.1212/WNL.0b013e31826e25df
25. Van der Zee J, Van Langenhove T, Kovacs GG et al (2014) Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. doi:10.1007/s00401-014-1298-7
26. Le Ber I, Camuzat A, Guillot-Noel L et al (2013) C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis 34:485–499. doi:10.3233/JAD-121456
27. Snowden JS, Rollinson S, Thompson JC et al (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135:693–708. doi:10.1093/brain/awr355
28. Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330. doi:10.1016/S1474-4422(12)70043-1
29. Boeve BF, Boylan KB, Graff-Radford NR et al (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765–783. doi:10.1093/brain/aws004
30. Cruts M, Gijselinck I, van der Zee J et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920–924. doi:10.1038/nature05017
31. Gass J, Cannon A, Mackenzie IR et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988–3001. doi:10.1093/hmg/ddl241
32. Pickering-Brown SM, Rollinson S, Du Plessis D et al (2008) Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 131:721–731. doi:10.1093/brain/awm331
33. Van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ɛ4 allele. Lancet Neurol 10:280–288. doi:10.1016/S1474-4422(10)70306-9
34. Ryan NS, Rossor MN (2010) Correlating familial Alzheimer’s disease gene mutations with clinical phenotype. Biomark Med 4:99–112. doi:10.2217/bmm.09.92
35. Larner AJ, Doran M (2006) Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J Neurol 253:139–158. doi:10.1007/s00415-005-0019-5
36. Godbolt AK, Beck JA, Collinge J et al (2004) A presenilin 1 R278I mutation presenting with language impairment. Neurology 63:1702–1704
37. Van Blitterswijk M, Baker MC, DeJesus-Hernandez M et al (2013) C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology 81:1332–1341. doi:10.1212/WNL.0b013e3182a8250c